2015
DOI: 10.1101/019505
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Diagnosis of coronary heart diseases using gene expression profiling; stable coronary artery disease, cardiac ischemia with and without myocardial necrosis

Abstract: Abstract-Cardiovascular disease including coronary artery disease and myocardial infarction is one of the leading causes of death in Europe, and is influenced by both environmental and genetic factors.With the advancements in genomic tools and technologies there is potential to predict and diagnose heart disease using molecular data from analysis of blood cells. We analyzed gene expression data from blood samples taken from normal people (n=21), non-significant coronary artery disease (n=93), patients with uns… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 25 publications
(14 reference statements)
0
2
0
Order By: Relevance
“…We aim to support precision medicine in HF and other CVDs by investigating genes associated with CVDs and analyzing their variants and expression levels that correlate with disease phenotype. RNA-seq-driven gene expression analysis has the potential to reveal novel and sensitive biomarkers and stratify CVD patient populations based on their disease risk [11]. While DNA-based gene variant analysis can assist in diagnosis and plan personalized treatments, integrating and/or validating sequential—one after another—gene expression and variant analyses will certainly advance our understanding of CVD biology.…”
Section: Introductionmentioning
confidence: 99%
“…We aim to support precision medicine in HF and other CVDs by investigating genes associated with CVDs and analyzing their variants and expression levels that correlate with disease phenotype. RNA-seq-driven gene expression analysis has the potential to reveal novel and sensitive biomarkers and stratify CVD patient populations based on their disease risk [11]. While DNA-based gene variant analysis can assist in diagnosis and plan personalized treatments, integrating and/or validating sequential—one after another—gene expression and variant analyses will certainly advance our understanding of CVD biology.…”
Section: Introductionmentioning
confidence: 99%
“…84% of overlapping with heart, indicating that study of peripheral blood transcriptase can be an economic and readily accessible tool for proxy gene expression in other tissues [17]. Though many studies have focused in the domain of differential expression in CVD outcomes, in [18], the authors have focused on using differential expression for classifying the patient record outcomes. Such an approach provides efficacy to improve the diagnosis to sub-classify patients.…”
mentioning
confidence: 99%